Insulin receptor substrate 1 (IRS-1) is a major signaling molecule activated by the insulin and insulin-like growth factor I receptors. Recent data obtained in different cell models suggested that in addition to its conventional role as a cytoplasmic signal transducer, IRS-1 has a function in the nuclear compartment. However, the role of nuclear IRS-1 in breast cancer has never been addressed. Here we report that in estrogen receptor a (ERa)-positive MCF-7 cells, (1) a fraction of IRS-1 was translocated to the nucleus upon 17-b-estradiol (E2) treatment; (2) E2-dependent nuclear translocation of IRS-1 was blocked with the antiestrogen ICI 182,780; (3) nuclear IRS-1 colocalized and co-precipitated with ERa; (4) the IRS-1:ERa complex was recruited to the E2-sensitive pS2 gene promoter. Notably, IRS-1 interaction with the pS2 promoter did not occur in ERa-negative MDA-MB-231 cells, but was observed in MDA-MB-231 cells retransfected with ERa. Transcription reporter assays with E2-sensitive promoters suggested that the presence of IRS-1 inhibits ERa activity at estrogen-responsive elementcontaining DNA. In summary, our data suggested that nuclear IRS-1 interacts with ERa and that this interaction might influence ERa transcriptional activity.
Introduction
The insulin receptor substrate 1 (IRS-1) is a major signaling substrate of the insulin receptor (IR) and the insulin-like growth factor I (IGF-I) receptor (IGF-IR) (Yenush and White, 1997; White, 1998; Burks and White, 2001) . Aberrant expression of IRS-1 has been associated with pathogenesis of many diseases, including diabetes and cancer (Yenush and White, 1997; White, 1998; Surmacz, 2000; Burks and White, 2001 ). Activated IRS-1 transmits signals from IGF-IR and IR by sequestering multiple effector molecules and stimulating different signaling pathways, including the PI-3K/Akt and ERK1/2 pathways (Yenush and White, 1997; White, 1998; Burks and White, 2001 ). In addition to its conventional role as a cytoplasmic signaling molecule, IRS-1 appears to function in the nuclear compartment. Several rigorously controlled studies demonstrated that nuclear IRS-1 can be found in cells transformed by oncogenic proteins, for example, T antigens of the JCV (Lassak et al., 2002) and SV40 viruses, and v-src (Tu et al., 2002) . Nuclear translocation of IRS-1 has also been described in mouse embryo fibroblasts stimulated with IGF-I (Tu et al., 2002; Sun et al., 2003) , 32D murine cells (Sciacca et al., 2003) , osteoblasts (Seol and Kim, 2003) , and hepatocytes (Boylan and Gruppuso, 2002) . The mechanism by which IRS-1 is targeted to the nucleus is unknown. The observations from different cell models suggested that although IRS-1 contains putative nuclear localization signals (NLSs), it is most likely chaperoned to the nucleus by other proteins, such as viral antigens Tu et al., 2002) . The nuclear localization of IRS-1 requires specific IRS-1 domains, but these requirements appear to be different depending on the experimental system. For instance, in JCV T-antigenexpressing cells, nuclear localization of IRS-1 depends on its pleckstrin homology domain (Lassak et al., 2002) , while in IGF-I-stimulated cells, the phosphotyrosine binding domain is required .
The biological relevance of nuclear IRS-1 in various cell backgrounds has yet to be determined. One recent study demonstrated that in mouse embryo fibroblasts stimulated with IGF-I, IRS-1 accumulated in the nucleoli and interacted with the upstream binding factor 1 (UBF1), a regulator of RNA polymerase I (Tu et al., 2002) . In this cell model, the presence of nucleolar IRS-1 coincided with increased rRNA synthesis (Tu et al., 2002) .
In breast cancer, IRS-1 overexpression has been associated with tumor development, hormone independence, and antiestrogen resistance (Surmacz, 2000) . These effects have been attributed to increased tyrosine phosphorylation of IRS-1 and potentiation of its downstream signaling to Akt (Surmacz, 2000; Sachdev and Yee, 2001) . In hormone-dependent breast cancer cell lines and breast tumors, the expression of IRS-1 is strongly correlated with estrogen receptor a (ERa), and numerous studies demonstrated that IRS-1 is one of the central elements of ERa/IGF-I crosstalk (Surmacz, 2000; Chan et al., 2001; Sachdev and Yee, 2001) . It has been well established that ERa can activate IRS-1 transcription acting on IRS-1 promoter (Lee et al., 1999; Molloy et al., 2000; Mauro et al., 2001) . In addition, our recent data suggested that unliganded ERa can upregulate IGF-I signaling by decreasing IRS-1 degradation through proteasomal pathways (Morelli et al., 2003) . The existence of nuclear IRS-1 in breast cancer cells and its possible role in the regulation of gene expression have never been addressed. Here we studied whether 17-bestradiol (E2) can induce nuclear translocation of IRS-1 and if nuclear IRS-1 can associate with and modulate the action of ERa.
Results

E2 stimulates nuclear translocation of IRS-1 in MCF-7 cells, and nuclear IRS-1 interacts with ERa
The subcellular localization of IRS-1 and ERa was studied in MCF-7 cells stimulated with E2 for different times, from 15 min to 72 h. The images obtained by immunostaining and confocal microscopy are shown in Figure 1 . Under serum-free medium (SFM) conditions, IRS-1 was present mainly in the cytoplasm, especially in the perinuclear area, while ERa localized in the nucleus and was weakly detectable in the cytoplasm (Figure 1 ). In 95% of untreated cells (SFM), colocalization of IRS-1 and ERa was not observed. At 15 min of E2 treatment, the staining of both proteins resembled that at time 0. At 1 and 4 h, 80% of cells displayed weak nuclear IRS-1 staining and strong nuclear expression of ERa. At these time points, nuclear colocalization of ERa and IRS-1 was detectable in B25% of cells (data not shown). At 8, 24, and 48 h of E2 treatment, ERa was expressed almost exclusively in the nucleus, while IRS-1 was abundant in both cellular compartments (Figure 1) . Furthermore, at these time points, evident nuclear colocalization of ERa and IRS-1 was observed in 60-70% of the cells (Figure 1) . At 72 h, nuclear presence of IRS-1 became greatly reduced compared with that of earlier time points, while ERa remained nuclear. At this time, colocalization of ERa and IRS-1 was nearly undetectable (data not shown).
The above experiments were repeated several times with reproducible results. The specificity of IRS-1 staining was confirmed with other anti-IRS-1 polyclonal antibodies (pAbs), specifically anti-IRS-1 CT and anti-IRS-1 pre-CT (both from UBI), and pAb C20 (Santa Cruz). The staining was negative when the primary Abs were omitted or blocking peptide was used, as shown by us before in other cell models (Tu et al., 2002) . In addition, we evaluated the specificity of staining procedures using BT-20 breast cancer cells, which are ERa and IRS-1 negative but express IRS-2 (Figure 1 , inset). BT-20 cells were treated for 24 and 48 h with E2 and subjected to the same staining protocol as described for MCF-7 cells. Both IRS-1 and ERa were undetectable in BT-20 cells (Figure 1 ).
The localization of ERa and IRS-1 was further pursued in subcellular protein fractions. Cytoplasmic and nuclear proteins were obtained from MCF-7 cells treated with E2 for 24 h or left untreated. Under SFM conditions, ERa was present in the cytoplasmic and nuclear compartments. As expected, upon E2 treatment the nuclear abundance of ERa significantly increased, while the abundance of the cytoplasmic ERa significantly decreased (Figure 2a ). In parallel, E2 stimulation significantly (B 3.0-fold) upregulated nuclear amounts of IRS-1 ( Figure 2 ). Despite nuclear translocation of IRS-1, its abundance in the cytoplasm remained similar in treated and untreated cells (Figure 2a) , which is consistent with the fact that E2 can induce IRS-1 expression (Lee et al., 1999; Molloy et al., 2000) . The expression of two cytoplasmic proteins GRB-2 and GAP-DH, and a nuclear protein c-Jun, was assessed as control of lysate purity (Figure 2a ). Confocal microscopy results suggested nuclear colocalization of IRS-1 and ERa. To confirm this observation, we studied IRS-1 and ERa interactions by immunoprecipitation (IP) and Western blotting (WB) using nuclear protein fractions obtained form MCF-7 cells grown in SFM or treated with E2 for 24 h (Figure 2b ). ERa was found in IRS-1 immunoprecipitates in treated and untreated cells, with greater abundance of ERa/IRS-1 complexes in E2-stimulated cells (Figure 2b) . Similarly, IRS-1 co-precipitated with nuclear ERa under E2 treatment (data not shown).
Comparison of ERa content in total nuclear proteins vs IRS-1-associated proteins suggested that only a fraction (B10%) of ERa co-precipitates with IRS-1.
IRS-1 is recruited to the ERE-containing pS2 promoter in MCF-7 cells Nuclear colocalization and co-precipitation of ERa and IRS-1 suggested that both molecules could be recruited to the same regulatory sequences in DNA. The binding of ERa and IRS-1 to the estrogen-responsive element (ERE)-containing domain of the pS2 gene promoter was assessed with chromatin immunoprecipitation (ChIP) and reverse ChIP (Re-ChIP) assays (Figure 3 ). First, we tested the dynamics of ERa association with the pS2 promoter sequences. Soluble chromatin obtained from To test whether IRS-1 belongs to the ERa multicomplex recruited to the pS2 promoter, we performed Re-ChIP experiments, following the protocol described for ERa interacting proteins (Reid et al., 2003) . In our Re-ChIP experiments, the original ERa ChIP pellets were eluted and precipitated with IRS-1 Abs and the pS2 promoter sequences were detected in IRS-1 ReChIPs by PCR. We found pS2 DNA in IRS-1 Re-ChIPs at all time points, which indicated that IRS-1 and ERa belong to the same protein complex, and that the complex is associated with the ERE-pS2 promoter in E2-stimulated MCF-7 cells. Notably, the greatest amounts of pS2 DNA in IRS-1 Re-ChIPs were present in cells stimulated with E2 for 24 h (Figure 3) .
To extend the above observations, we examined the presence of other regulatory proteins in ERa transcriptional complexes in MCF-7 cells stimulated with E2 for 24 h. Figure 4 illustrates pS2 promoter occupancy by two proteins known to regulate ERa-dependent transcription, ERa coactivator SRC-1 and polymerase II (pol II). In parallel, the association of ERa and IRS-1 under the same conditions was assessed by ChIP and two-way Re-ChIP assays. The results confirmed that E2 stimulates the recruitment of the ERa:IRS-1 complex to the pS2 promoter in MCF-7 cells (Figure 4a and b). In the same experiment, neither ERa nor IRS-1 was recruited to the GAP-DH promoter that is not regulated by ERa (Metiver et al., 2002) (Figure 4c) . Notably, the association of ERa and IRS-1 with pS2 DNA coincided with the recruitment of SRC-1 and pol II to the same promoter ( Figure 4d ).
Absence of ERa blocks nuclear IRS-1 translocation
The role of ERa in the nuclear translocation of IRS-1 was probed in MCF-7 cells pretreated with the antiestrogen ICI 182,780 (ICI) for 6 h ( Figure 5 ). This treatment has been chosen based on preliminary tests establishing the dynamics of ICI-dependent downregulation of ERa and IRS-1. IRS-1 is a stable protein with a half-life of B10 h (Morelli et al., 2003) and only a longterm ICI treatment (48-74 h) can substantially decrease its levels (Salerno et al., 1999) , while short-term ICI exposure is sufficient to degrade ERa (Reid et al., 2003) . Indeed, a 6 h ICI treatment dramatically reduced cytoplasmatic and nuclear ERa expression without affecting IRS-1 levels (Figure 5a and b) . In ICIpretreated cells, E2 did not stimulate nuclear translocation of IRS-1, as demonstrated by WB (Figure 5a ) and confocal microscopy ( Figure 5b ). However, E2 induced nuclear translocation of IRS-1 in untreated cells expressing normal ERa levels (Figures 1, 2 and 5a ). Low amounts of nuclear IRS-1 were found under SFM IRS-1 does not associate with the pS2 promoter in ERanegative MDA-MB-231 cells
The requirement of ERa for E2-dependent nuclear translocation of IRS-1 was further investigated with MDA-MB-231 and MDA-MB-231/ER breast cancer cells ( Figure 6 ). MDA-MB-231 cells are ERa negative but express IRS-1 on a level similar to that found in MCF-7 cells (Bartucci et al., 2001; Morelli et al., 2003) . MDA-MB-231/ER cells have been developed in our laboratory by stable transfection of MDA-MB-231 cells with an ERa expression vector (Morelli et al., 2003) . The association of ERa and IRS-1 with the pS2 promoter was studied in both cell lines by ChIP assays. In MDA-MB-231 cells, neither ERa nor IRS-1 was found on the pS2 promoter. However, reintroduction of ERa allowed the association of both molecules with pS2 ERE sequences in response to E2 treatment ( Figure 6 ).
IRS-1 modulates ERa transcriptional activity
Because IRS-1 and ERa are recruited to E2-sensitive promoters, we tested whether the presence of IRS-1 may affect ERa transcriptional activity at ERE sites. This possibility was examined with transactivation assays employing an ERE reporter plasmid. The plasmid, ERE-Luc, was transiently transfected into cells either together with ERa expression vector only or with a mixture of ERa and IRS-1 expression plasmids. The transfected cells were left untreated or were treated with E2 for 24 h (Figure 7 ). To assess E2-dependent transcription in a controlled environment, we used ERa-and IRS-1-negative COS-7 and BT-20 cells (Figures 1 and 7b) , which allowed measurements of transcriptional activity in the presence or absence of studied molecules. In addition, transactivation experiments were performed in MCF-7 cells expressing endogenous IRS-1 and ERa.
The transactivation assays indicated that the presence of IRS-1 significantly decreased ERa activation of ERE promoters in all cell lines stimulated with E2 (Figure 7a) . Specifically, in COS-7, BT-20, and MCF-7 cells, cotransfection of IRS-1 reduced ERa activation of ERE by B50, B39, and B44%, respectively. The transfection of IRS-1 alone did not stimulate ERE transcription (Figure 7a) .
In addition to ERE reporter assays with reporter plasmids, we assessed transcriptional activation of the pS2 gene in COS-7 cells transfected with either ERa, IRS-1, or a combination of ERa plus IRS-1. COS-7 cells were selected for this assay as they proved to be the most E2-responsive and the best transfectable cell model (Figure 7a ). The levels of pS2 mRNA in COS-7 cells transfected with different plasmids were studied using Figure 5 Effects of ERa downregulation on nuclear translocation of IRS-1. MCF-7 cells synchronized in SFM were pretreated with 10 nM ICI 182,780 for 6 h, and then stimulated with 10 nM E2 for 24 h or left untreated in SFM (a). The levels of IRS-1 (IRS) and ERa (ER) were detected in 50 mg of cytoplasmatic and nuclear proteins with specific Abs, as described in Materials and methods. The results were obtained after repetitive stripping and reprobing of the same filter. (b) MCF-7 cells were pretreated with ICI and then stimulated with E2 or left in SFM as described in (a). The localization of IRS-1 (IRS) and ERa (ER) was studied by confocal microscopy, as described in (Figure 7b ). The amounts of a constitutively expressed 36B4 mRNA were assessed in the same samples. The results suggested that E2 stimulated pS2 mRNA expression (B3-fold) in ERa-transfected cells, compared with vector-only-transfected cells. This effect of E2 was significantly reduced in cells cotransfected with ERa and IRS-1, confirming the trend observed in ERE luciferase reporter assays. Notably, ERa expression was similar in the 'ER' and 'ER þ IRS' populations, ruling out the possibility that differences in pS2 transcription were related to unequal ERa expression (Figure 7b ).
RT-PCR
Discussion
The interactions between IGF-IR and ER signaling systems have been implicated in the development of the neoplastic phenotype in mammary epithelial cells (Surmacz, 2000; Yee and Lee, 2000; Sachdev and Yee, 2001) . In this context, IRS-1, a molecule that activates multiple growth and survival pathways, has been found to be one of the central elements of IGF-IR/ER crosstalk. Several reports documented that E2 can increase IRS-1 transcription, while ICI inhibits IRS-1 mRNA levels (Surmacz, 2000; Yee and Lee, 2000; Sachdev and Yee, 2001) . Furthermore, the expression of ERa seems to stabilize IRS-1 protein and potentiate IRS-1 signaling through the PI-3K/Akt pathway (Morelli et al., 2003) . In turn, the activation of IRS-1/PI-3K/ Akt by growth factors can stimulate ERa by increasing its phosphorylation (Lannigan, 2003) . In MCF-7 cells, overexpression of IRS-1 has been shown to induce estrogen independence (Surmacz and Burgaud, 1995) , while downregulation of IRS-1 resulted in increased sensitivity to E2 (Ando et al., 1998) .
Here we report on a novel aspect of ERa/IGF-I crosstalk involving nuclear ERa/IRS-1 interactions. Specifically, we demonstrated that (1) in MCF-7 cells, IRS-1 can be translocated from the cytoplasm to the nucleus following E2 treatment; (2) nuclear transloca- Figure 7 Effects of IRS-1 on ERa transcriptional activity at ERE promoters. (a) Transactivation assays. The transcriptional activity of ERa on ERE promoters in the presence or absence of IRS-1 was evaluated using luciferase reporter system, as described in Materials and methods. COS-7, BT-20, and MCF-7 cells were transfected with DNA mixtures containing ERE reporter plasmid alone (C), ERE þ plasmid pHEGO encoding ERa (ER), ERE þ ER þ plasmid encoding IRS-1 (ER þ IRS), or ERE þ IRS-1 (IRS). The activity of the ERE promoter in each experimental setting is represented by relative Luc units. The results are means7s.e. from several experiments. In all experimental systems, the difference between E2-stimulated Luc activities in ER vs ER þ IRS transfectants was statistically significant (Po0.05). (b) Effect of IRS-1 expression on pS2 mRNA levels. Upper panel: COS-7 cells were transfected with different plasmids and stimulated with E2 or left untreated, as described above. ERa and IRS-1 expression in transfected cells was detected by WB in 50 mg of total protein lysates. Lower panel: The abundance of pS2 and 36B4 mRNAs in COS-7 cells transfected with different plasmids was detected by RT-PCR, as described in Materials and methods Nuclear IRS-1/ERa interactions C Morelli et al tion of IRS-1 is blocked with ICI and does not occur in ERa-negative cells; (3) nuclear IRS-1 interacts with ERa; (4) nuclear IRS-1 is corecruited with ERa to the ERE-containing pS2 promoter; and (5) the presence of IRS-1 decreases ERa transcription at ERE promoters. Nuclear localization of IRS-1 has recently been described in different cellular systems (Lassak et al., 2002; Prisco et al., 2002; Sun et al., 2003; Tu et al., 2002; Sciacca et al., 2003) . The mechanism by which IRS-1 enters cell nucleus is still not clear. Although IRS-1 contains putative NLS, it is thought that IRS-1 is chaperoned to the nucleus by other proteins, for instance, by T antigens of the SV40 and JC viruses (Lassak et al., 2002) . The transporting molecules involved in IGF-IR-dependent IRS-1 nuclear translocation are yet unknown.
In our experimental system, E2-dependent nuclear translocation of IRS-1 and its interaction with the pS2 promoter were totally blocked when ERa was downregulated by ICI ( Figure 5 ) and did not occur in MDA-MB-231 cells that are ERa negative but express ERa (Vladusic et al., 2000) (Figure 6 ). However, re-expression of ERa allowed association of IRS-1 with the pS2 sequences. These observations suggest that nuclear function of IRS-1 in response to E2 requires ERa. Notably, a small amount of nuclear IRS-1 was found in unstimulated MCF-7 cells, which could result from basal ERa activity.
The prerequisite for nuclear translocation of IRS-1 in response to E2 is most likely the formation of the ERa:IRS-1 complex in the cytoplasm. ERa association with cytoplasmic signaling molecules is not unusual. Recently, ERa has been shown to bind the PI-3K/Akt complex (Simoncini et al., 2000; Sun et al., 2001) , and to interact with growth factor receptor docking protein Shc (Song et al., 2002) as well as with IGF-IR (Kahlert et al., 2000) . Similarly, we reported that unliganded ERa can associate with cytoplasmic IRS-1 in MDA-MB-231/ER cells (Morelli et al., 2003) . Our preliminary data suggest that ERa/IRS-1 binding involves at least two different IRS-1 domains, and does not depend on IRS-1 tyrosine phosphorylation (Surmacz et al., unpublished data) .
Our previous findings (Morelli et al., 2003) and this report suggest that only a fraction of ERa binds to IRS-1 (B10% of nuclear ERa) (Figure 2b ), according to rough estimations based on coprecipitation procedures. However, if the linkage between ERa and IRS-1 is labile, coprecipitation assays might underestimate the actual extent of their association. In fact, the results obtained with confocal microscopy in intact cells suggested that in some cells, B30% of ERa colocalized with IRS-1. Because only a fraction of ERa associates with IRS-1, it is understandable that nuclear accumulation of IRS-1 upon E2 stimulation might occur slower than that of ERa. The nuclear presence of IRS-1 in E2-treated MCF-7 cells was limited to B72 h, while ERa remained nuclear for longer times. It needs to be discovered whether IRS-1 disappearance from the nucleus is caused by proteolysis or by translocation to the cytoplasmic compartment.
In this work, we report for the first time that nuclear IRS-1 can interact with ERa on ERE-containing chromatin regions. In our experimental system, IRS-1 was recruited together with ERa and other proteins involved in ERa transcription (SRC-1 and pol II) to the pS2 promoter (Figures 3, 4, and 6 ). The possibility that IRS-1 modulates ERa-dependent transcription was addressed with transient transfection reporter assays. With this methodology, we noted inhibition of ERa activity by IRS-1 in several cell lines (Figure 7a ). We also found that overexpression of IRS-1 inhibits E2/ ERa-dependent transcription of the endogenous pS2 gene in COS-7 cells (Figure 7b ). A hypothetical model explaining the inhibitory effect of IRS-1 could be proposed on the basis of the recent discovery that ERa-dependent transcription from ERE sites requires cyclic proteasomal degradation of ERa (Reid et al., 2003) . Because IRS-1 and ERa compete for the same degradation machinery (Morelli et al., 2003) , it is possible that the presence of nuclear IRS-1 interferes with ERa proteolysis, and thus with ERa transcription.
IRS-1 modification of ERa activity is probably restricted to certain transcriptional complexes, as we did not observe significant effects of IRS-1 on ERadependent transcription at AP-1 sites. In addition, our new data suggest that the association of IRS-1 with ERE promoters can be transiently inhibited by its recruitment to activated IGF-I receptors (Surmacz et al., unpublished data) .
The presence of nuclear IRS-1 in cellular systems needs to be further evaluated in human clinical material. The expression of nuclear IRS-1 in primary breast tumors has been reported by Schnarr et al. (2000) , but the authors did not speculate on the biological relevance of this phenomenon. Our preliminary data confirmed that nuclear IRS-1 can be detected in mammary tissue sections and that its expression correlates with ERa (data not shown). Larger studies evaluating the correlations of cytoplasmatic and nuclear IRS-1 with other tumor markers are underway in our laboratory.
In summary, our data suggest that IRS-1 can interact with ERa in the nucleus of breast cancer cells and modulate ERa transcriptional activity. We postulate that nuclear ERa/IRS-1 interactions represent a new paradigm in IGF-IR/ER crosstalk.
G418. BT-20 cells were grown in DMEM:F12 with 10% fetal bovine serum (FBS). COS-7 and HeLa cells were grown in DMEM supplemented with 10% FBS. In the experiments requiring E2-and serum-free conditions, the cells were cultured in phenol red-free SFM (Guvakova and Surmacz, 1997) .
Cell treatments
E2 (Sigma) and the antiestrogen ICI 182,780 (Tocris Cookson) were used at a concentration of 10 nM.
Detection of IRS-1 and ERa by confocal microscopy
Confluent cultures (50%) grown on coverslips were fixed in 3% paraformaldehyde, permeabilized with 0.2% Triton X-100, washed three times with PBS, and incubated for 1 h with a mixture of primary Abs (pAbs) recognizing IRS-1 and ERa. The anti-IRS-1 CT pAb (UBI) or anti-IRS-1 pre-CT pAb (UBI) at 2 mg/ml was used for IRS-1 staining; F-10 monoclonal Ab (mAb) (Santa Cruz) at 2 mg/ml was used to detect ERa. Following the incubation with primary Abs, the slides were washed three times with PBS, and incubated with a mixture of secondary Abs. A fluorescein-conjugated donkey anti-mouse IgG (Calbiochem) was used as a secondary Ab for ERa and a rhodamine-conjugated donkey anti-rabbit IgG (Calbiochem) was used for IRS-1. The cellular localization of IRS-1 and ERa was studied with Bio-Rad MRC 1024 confocal microscope connected to a Zeiss Axiovert 135M inverted microscope with Â 600 magnification. The optical sections were taken at the central plane. The fluorophores were imaged separately to ensure no excitation/emission wavelength overlap. In control samples, the staining was performed with the omission of the primary Abs.
Immunoprecipitation and Western blotting
The cytoplasmic and nuclear proteins were obtained from 70% cultures. The cytoplasmic lysis buffer contained the following: 50 mM HEPES pH 7.5, 150 mM NaCl, 1% Triton X-100, 1.5 mM MgCl 2 , EGTA 10 mM pH 7.5, glycerol 10%, inhibitors (0.1 mM Na 3 VO 4 , 1% PMSF, 20 mg/ml aprotinin). Following the collection of cytoplasmic proteins, the nuclei were lysed with the buffer containing 20 mM HEPES pH 8, 0.1 mM EDTA, 5 mM MgCl 2 , 0.5 M NaCl, 20% glycerol, 1% NP-40, inhibitors (as above). A 25-50 mg portion of protein lysates was used for WB, while 500 mg was used for IP. The following mAbs and pAbs were employed: anti-IRS-1 CT pAb (UBI) for WB and IP; anti-ERa F-10 mAb (Santa Cruz) for WB and IP; anti-GAP-DH mAb (Research Diagnostics Inc.) for WB, antic-Jun mAb (Santa Cruz) for WB, anti-GRB2 mAb (Transduction Laboratories) for WB.
In all IPs, protein lysates were first incubated with primary Abs at 41C for 4 h in HNTG buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol, 0.1 mM Na 3 VO 4 ), and then immune complexes were precipitated for 1 h with appropriate beads, specifically with protein A agarose (Calbiochem) for IPs with polyclonal Abs and anti-mouse IgG agarose (Sigma) for IPs with mouse mAbs. In control samples, the primary Abs were substituted with nonimmune IgGs (rabbit or mouse, depending on the source of the primary Abs). The immunoprecipitated proteins were washed three times with HNTG buffer, separated on a 4-15% polyacrylamide denaturing gel, analysed by WB, and visualized by ECL chemiluminescence (Amersham). The intensity of bands representing relevant proteins was measured by Scion Image laser densitometry scanning program.
Luciferase reporter assays
The experiments were performed using COS-7, BT-20, and MCF-7 cell lines. The cells were grown in 24-well plates. At 70% confluence, the cultures were transfected for 6 h with 0.5 mg DNA/well using Fugene 6 (Roche) (DNA : Fugene 3 : 1). All transfection mixtures contained 0.3 mg of the reporter plasmid, ERE-Luc, encoding the firefly luciferase (Luc) cDNA under the control of the TK promoter and three ERE sequences. ERE-Luc was cotransfected with the ERa expression vector pSG5-HEGO, alone or in combination with the IRS-1 expression vector pCMV-IRS-1. To maintain the same DNA input in all transfection mixtures, the samples were adjusted with an empty vector (pcDNA3 or pSG5). In addition, to assess transfection efficiency, each of the DNA mixtures contained 50 ng of pRL-TK-Luc, a plasmid encoding Renilla luciferase (RI Luc) (Promega). Upon transfection, the cells were shifted to SFM for 12 h and then treated with 10 nM E2 for 24 h, or left untreated in SFM. Luciferase activity (Luc and RI Luc) in cell lysates was measured using Dual Luciferase Assay System (Promega) following the manufacturer's instructions. The values obtained for Luc were normalized to that of RI Luc to generate relative Luc units representing EREdependent transcription.
Chromatin immunoprecipitation
We followed ChIP methodology described by Shang et al. (2000) with minor modifications. MCF-7, MDA-MB-231, and MDA-MB-231/ER cells were grown in 100 mm plates. Confluent cultures (90%) were shifted to SFM for 24 h and then treated with 10 nM E2 for 1-24 h, or left untreated in SFM. Following treatment, the cells were washed twice with PBS and crosslinked with 1% formaldehyde at 371C for 10 min. Next, the cells were washed twice with PBS at 41C, collected and resuspended in 200 ml of lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 8.1) and left on ice for 10 min. Then, the cells were sonicated four times for 10 s at 30% of maximal power (Fisher Sonic Dismembrator) and collected by centrifugation at 41C for 10 min at 14 000 rpm. The supernatants were collected and diluted in 1.3 ml of IP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl pH 8.1, 16.7 mM NaCl) followed by immunoclearing with 80 ml of sonicated salmon sperm DNA/ protein A agarose (UBI) for 1 h at 41C. The precleared chromatin was immunoprecipitated for 12 h with specific Abs, specifically anti-ERa C-terminus mAb F-10 (Santa Cruz) for ERa, and anti-IRS-1 C-terminus pAb (UBI) for IRS-1, antipol II CTD4H8 mAb for pol II (UBI), and anti-SRC1 1135 mAb for SRC1 (UBI). After this, 60 ml of salmon sperm DNA/ protein A agarose was added and precipitation was continued for 2 h at 41C. After pelleting, precipitates were washed sequentially for 5 min with the following buffers: Wash A (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 150 mM NaCl), Wash B (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM NaCl), and Wash C (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH 8.1), and then twice with TE buffer (10 mM Tris, 1 mM EDTA). The immune complexes were eluted with elution buffer (1% SDS, 0.1 M NaHCO 3 ). The eluates were reverse crosslinked by heating at 651C for 12 h and digested with proteinase K (0.5 mg/ml) at 451C for 1 h. DNA was obtained by phenol and phenol/chloroform extractions. A 2 ml portion of 10 mg/ml of yeast tRNA was added to each sample and DNA was precipitated with EtOH for 12 h at 41C and then resuspended in 20 ml of TE buffer. A 5 ml volume of each sample was used for PCR with pS2 promoter primers (forward) and 5 0 -AAGATGCGGCTGACTGTCGAA-3 0 (reverse). The PCR conditions were 45 s at 941C, 40 s at 581C, and 90 s at 721C. The amplification products obtained in 25 and 35 cycles were analysed in a 2% agarose gel and visualized by ethidium bromide staining. The intensity of bands representing relevant proteins was measured by Scion Image laser densitometry scanning program. In control samples, nonimmune IgG (rabbit for IRS-1 Abs and mouse for all other Abs, Santa Cruz) was used instead of the primary Abs.
Reverse ChIP
We followed the methodology described by Reid et al. (2003) . The pellets obtained by IP of soluble chromatin with IRS-1 and ERa Abs were eluted with 500 ml of Re-ChIP buffer (0.5 mM DTT, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl pH 8.1). Next, the eluate from ERa IP was precipitated with IRS-1 pAb (UBI) and the eluate from IRS-1 IP was precipitated with ERa mAb (Santa Cruz). The presence of the pS2 promoter sequences in the resulting Re-ChIP pellets was examined as described above for one-step ChIP.
RT-PCR
COS-7 cells were transfected with different plasmids for 24 h, as described in the transactivation assays methodology. Total RNA was isolated using TRIzol reagent (Invitrogen) according to the manufacturer's instructions. A 5 mg portion of total RNA was reverse transcribed (RT) at 371C for 30 min in 20 ml of buffer containing 200 U of M-MLV reverse transcriptase (Promega), 0.4 mg oligo-dT, 0.5 mM deoxynucleotide triphosphate (dNTP), and 24 U RNAsin. The reaction was terminated by heat denaturation for 5 min at 951C.
A 2 ml portion of RT products was used to simultaneously amplify pS2 and 36B4 (control) DNA sequences. The pS2 cDNA fragment (210 bp) was amplified using the following primers: 5 0 -TTCTATCCTAATACCATCGACG-3 0 (forward) and 5 0 -TTTGAGTAGTCAAAGTCAGAGC-3 0 (reverse). The 408 bp fragment of the 36B4 ribosomal phosphoprotein DNA was amplified with the following primers: 5 0 -CTCAA-CATCTCCCCCTTCTC-3 0 (forward) and 5 0 -CAAATCCCA-TATCCTCGTCC-3 0 (reverse) (Maggiolini et al., 2001) . The PCR amplification was performed using 1.25 U GoTaq DNA polymerase (Promega), 1 Â PCR buffer (10 mM Tris-HCl, 50 mM KCl), 2.5 mM MgCl 2 , 0.2 mM of each dNTP, and 1.5 pM of primers for pS2 or 0.5 pM primers for 36B4. PCR conditions were 30 s at 941C, 40 s at 591C, and 60 s at 721C for 30 cycles. PCR products (10 ml) were separated on a 1.2% agarose gel.
Statistical analysis
Student's t-test was used to analyze WB and transactivation data. Statistical significance was assumed at Po0.05.
